The update interpretation of 2020 EAU bladder cancer guideline (Part Ⅱ) ——the update of non-muscle-invasive bladder cancer / 中华泌尿外科杂志

ABSTRACT

The guideline content of non-muscle invasive bladder cancer(NMIBC) by European Association of Urology has been updated in 2020, mainly included ①Histological variant classification information of urothelial carcinoma has been added; ②The classification of BCG therapy failure has been revised; ③Immune checkpoint inhibitors has been approved for the treatment of BCG unresponsive high risk NMIBC. This paper is to introduce and summarize the main points of the updated guideline.